Maternal RSV Vaccination Strongly Reduces Infant Hospitalization Risk
New findings from a large UKHSA study presented at ESCMID Global 2026 show that maternal vaccination against respiratory syncytial virus (RSV), given at least 14 days before birth, lowers the risk of RSV-related hospitalizations among young infants by over 80%.
This article is based on a press release issued in connection with the ESCMID Global Congress 2026. The study abstract is referenced below.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in
